Conversely, individuals with obesity show increased oxygen consumption in the insula, operculum, bilateral precuneus, and posterior cingulate cortex, along with the ventral putamen and Rolandic operculum, but decreased oxygen uptake in the lower caudatepatterns associated with increased impulsivity towards food stimuli (128130)
GLP-1 Medications as a Starting Point GLP-1 medications including semaglutide (Wegovy) and tirzepatide (Zepbound) have changed the landscape of obesity treatment significantly
When used with insulin or sulfonylureas, GLP-1 RAs may increase hypoglycaemia risk, requiring dose adjustments of these medications
Mol Genet Metab 91:228233
Is the increased risk significant
For patients seeking a therapeutic modality independent of conventional pharmaceuticals Wegovy 0.5 mg (Semaglutide) and biological agents